An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results

Anthony Yazdani, Alban Bornet, Philipp Khlebnikov +4

Adverse drug events (ADEs) are a major safety issue in clinical trials. Thus, predicting ADEs is key to developing safer medications and enhancing patient outcomes. To support this…